Product NDC: | 0173-0441 |
Proprietary Name: | ZANTAC |
Non Proprietary Name: | ranitidine hydrochloride |
Active Ingredient(s): | 50 mg/50mL & nbsp; ranitidine hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0441 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019593 |
Marketing Category: | NDA |
Start Marketing Date: | 19921120 |
Package NDC: | 0173-0441-00 |
Package Description: | 50 mL in 1 BAG (0173-0441-00) |
NDC Code | 0173-0441-00 |
Proprietary Name | ZANTAC |
Package Description | 50 mL in 1 BAG (0173-0441-00) |
Product NDC | 0173-0441 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ranitidine hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19921120 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | RANITIDINE HYDROCHLORIDE |
Strength Number | 50 |
Strength Unit | mg/50mL |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |